Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 401–500 of 1,006
Yoshiike, Y., Kimura, T., Yamashita, S., Furudate, H., Mizoroki, T., Murayama, M., & Takashima, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003029 · Cited by 102
Mukherjee, A., & Williams, D. W. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.64 · Cited by 100
Ahuja, A., Dev, K., Tanwar, R. S., Selwal, K. K., & Tyagi, P. K. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.003 · Cited by 107
Matthews, D. C., Mao, X., Dowd, K., Tsakanikas, D., Jiang, C. S., Meuser, C., Andrews, R. D., Lukic, A. S., Lee, J., Hampilos, N., et al. (2021) · Brain · doi:10.1093/brain/awab222 · Cited by 97
Limón, I. D., Mendieta, L., Díaz, A., Chamorro, G., Espinosa, B., Zenteno, E., & Guevara, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.011 · Cited by 99
“neurotoxicity could also involve an NMDA receptor [25] and by”
BackgroundDinamarca, M. C., Ríos, J. A., & Inestrosa, N. C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00464 · Cited by 99
Poon, W. W., Carlos, A. J., Aguilar, B. L., Berchtold, N. C., Kawano, C. K., Zograbyan, V., Yaopruke, T., Shelanski, M., & Cotman, C. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463711 · Cited by 99
In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks
Burgold, S., Bittner, T., Dorostkar, M. M., Kieser, D., Fuhrmann, M., Mitteregger, G., Kretzschmar, H., Schmidt, B., & Herms, J. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0787-6 · Cited by 98
“They are comprised of fibrillar aggregates of the amyloid-b-peptide which has been shown to have synaptotoxic effects [10, 17, 18, 23].”
Torres, L., Robinson, S.-A., Kim, D.-G., Yan, A., Cleland, T. A., & Bynoe, M. S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1086-8 · Cited by 98
“reducing their surface expression [19].”
Synaptic plasticity in Alzheimer’s disease and healthy aging
Cuestas Torres, D. M., & Cardenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 98
Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
Nisticò, R., Pignatelli, M., Piccinin, S., Mercuri, N. B., & Collingridge, G. L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8324-3 · Cited by 105
“Moreover, a previous study demonstrated that Aβ activates STEP, which dephosphorylates a regulatory tyrosine site (tyr1472) on the GluN2B subunit, leading to internalization of NMDA receptors [93].”
Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease
Gong, Y., Lippa, C. F., Zhu, J., Lin, Q., & Rosso, A. L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.056 · Cited by 98
“…system; IRSp53, insulin receptor substrate . level (Thorns et al., 1997), gene expression (Hynd et al., 2003), channel activity (Shemer et al., 2006), and trafficking (Snyder et al., 2005) in vivo and in vitro from human AD postmortem tissue, transgenic AD mouse models and neuronal culture.”
BackgroundMorice, E., Andreae, L. C., Cooke, S. F., Vanes, L., Fisher, E. M. C., Tybulewicz, V. L. J., & Bliss, T. V. P. (2008) · Learning & Memory · doi:10.1101/lm.969608 · Cited by 98
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Mroczko, B., Groblewska, M., Litman-Zawadzka, A., Kornhuber, J., & Lewczuk, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071884 · Cited by 97
Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.043 · Cited by 97
“…from sequential processing of the APP holoprotein, induces synaptic dysfunction (Almeida et al., 2005; Hsieh et al., 2006; Jacobsen et al., 2006; Snyder et al., 2005), oxidative damage (Bartley et al., 2012; Wan et al., 2011), tau aggregation (Chabrier et al., 2012; Oddo et al., 2006), and…”
InfluentialSynaptogenic effect of APP -Swedish mutation in familial Alzheimer’s disease
Zhou, B., Lu, J. G., Siddu, A., Wernig, M., & Südhof, T. C. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn9380 · Cited by 106
Reelin protects against amyloid β toxicity in vivo
Lane-Donovan, C., Philips, G. T., Wasser, C. R., Durakoglugil, M. S., Masiulis, I., Upadhaya, A., Pohlkamp, T., Coskun, C., Kotti, T., Steller, L., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa6674 · Cited by 96
Failures to reconsolidate memory in a mouse model of Alzheimer’s disease
Ohno, M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.05.001 · Cited by 95
“…(Blanchard et al., 2008; Dewachter et al., 2009; Dickey et al., 2004; Dickey et al., 2003; Gong et al., 2006; Gong et al., 2004; Ma et al., 2007; Snyder et al., 2005; Wu et al., 2006), providing some mechanistic basis that may link Aβ accumulation and impairments of memory consolidation or…”
BackgroundGlutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
Cassano, T., Pace, L., Bedse, G., Michele Lavecchia, A., De Marco, F., Gaetani, S., & Serviddio, G. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151218132725 · Cited by 95
Salahuddin, P., Fatima, M. T., Abdelhameed, A. S., Nusrat, S., & Khan, R. H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.065 · Cited by 105
Shrivastava, A. N., Aperia, A. C., Melki, R., & Triller, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.026 · Cited by 98
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Toniolo, S., Sen, A., & Husain, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239318 · Cited by 94
Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons
Gao, C., & Wolf, M. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05597.x · Cited by 95
Zameer, A., Kasturirangan, S., Emadi, S., Nimmagadda, S. V., & Sierks, M. R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.068 · Cited by 103
Posttranslational Modifications Regulate the Postsynaptic Localization of PSD-95
Vallejo, D., Codocedo, J. F., & Inestrosa, N. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9745-1 · Cited by 103
“Regarding the role of NMDARs in synaptic transmission , it is thought that the palmitoylation of PSD-95 affects NMDAR synaptic trafficking, clustering, and function as, conversely, the activation of NMDAR destabilizes PSD-95, releasing PSD-95 molecules from the dendritic spine [9] .”
InfluentialGuan, P.-P., Cao, L.-L., & Wang, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115900 · Cited by 93
Dysregulation of Calcium Homeostasis in Alzheimer’s Disease
Small, D. H. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9960-5 · Cited by 94
“[27] have proposed that effects of Ab on NMDA receptors may be mediated by a direct action on a7 nicotinic acetylcholine receptors (a7nAChR), as several studies report that Ab may bind directly to a7nAChRs.”
The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease
Lane-Donovan, C., & Herz, J. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075507 · Cited by 94
“Reelin activation of downstream kinases and enhancement of LTP is important for protection against A, which reduces LTP by enhancing NMDAR endocytosis via striatalenriched protein tyrosine phosphatase (80).”
Lord, A., Englund, H., Söderberg, L., Tucker, S., Clausen, F., Hillered, L., Gordon, M., Morgan, D., Lannfelt, L., Pettersson, F. E., et al. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06836.x · Cited by 93
“The mechanism of synaptic dysfunctions might possibly be mediated through direct interaction on α7 nicotinic receptors or NMDA (N-methyl-D-aspartate), AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole) or other glutamate receptors [13–16].”
Lv, C., Wang, L., Liu, X., Yan, S., Yan, S. S., Wang, Y., & Zhang, W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.019 · Cited by 95
“Recent results showed that oligomeric Ab could impair the synaptic function in the hippocampus (Selkoe, 2002) and entorhinal cortex (EC) (Origlia et al., 2008), two vulnerable areas that play a crucial role in learning and memory in AD (Witter et al., 1989; Braak et al., 1993; Suzuki and Amaral, 2004), by inducing def…”
InfluentialYiu, A. P., Rashid, A. J., & Josselyn, S. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.107 · Cited by 105
Foster, T. C., Kyritsopoulos, C., & Kumar, A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.012 · Cited by 98
“activity and is specific to GluN2B NMDA receptor subunit [86, 90].”
He, Y., Cui, J., Lee, J. C. M., Ding, S., Chalimoniuk, M., Simonyi, A., Sun, A. Y., Gu, Z., Weisman, G. A., Wood, W. G., et al. (2011) · ASN Neuro · doi:10.1042/an20100025 · Cited by 92
“Ab was shown to suppress NMDA-induced currents in cortical neurons, and this effect was attributed in part to alteration of signalling pathways leading to endocytosis of NMDA receptors (Snyder et al., 2005).”
BackgroundBiochemical Fractionation of Brain Tissue for Studies of Receptor Distribution and Trafficking
Hallett, P. J., Collins, T. L., Standaert, D. G., & Dunah, A. W. (2008) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0116s42 · Cited by 92
“Recent studies have shown that abnormal trafficking of receptors might underlie some neurological disorders, such as Parkinson’s disease, Alzheimer’s disease, and addiction (Dunah and Standaert, 2001; Wolf et al., 2003; Snyder et al., 2005).”
Resende, R., Pereira, C., Agostinho, P. M., Vieira, A. P., Malva, J. O., & Oliveira, C. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.071 · Cited by 102
Mateos, L., Akterin, S., Gil‐Bea, F., Spulber, S., Rahman, A., Björkhem, I., Schultzberg, M., Flores‐Morales, A., & Cedazo‐Mínguez, A. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00174.x · Cited by 92
“Moreover, Ab-peptide was found to attenuate NMDA-dependent signaling (44), on which Arc expression depends.”
Hanson, J. E., Ma, K., Elstrott, J., Weber, M., Saillet, S., Khan, A. S., Simms, J., Liu, B., Kim, T. A., Yu, G.-Q., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.030 · Cited by 90
“…and extrasynaptic NMDARs in health and disease are not fully understood, extrasynaptic GluN2B-containing NMDARs may mediate neurotoxicity in Alzheimer’s disease (AD) pathogenesis and other brain disorders (Hu et al., 2009; Li et al., 2011; Mony et al., 2009; Snyder et al., 2005; Um et al., 2012).”
Therapeutic potential of mGluR5 targeting in Alzheimer's disease
Kumar, A., Dhull, D. K., & Mishra, P. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00215 · Cited by 99
“Aβ mediated dysregulation of N-methyl-D-aspartate (NMDA) receptors has been hypothesized as a potential mechanism in the pathophysiology of AD (Miguel-Hidalgo et al., 2002; Molnár et al., 2004; Snyder et al., 2005; Shankar et al., 2007; Malinow, 2012).”
BackgroundSchubert, K. O., Föcking, M., Prehn, J. H. M., & Cotter, D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.123 · Cited by 97
The Monomer State of Beta-Amyloid: Where the Alzheimer's Disease Protein Meets Physiology
Giuffrida, M. L., Caraci, F., De Bona, P., Pappalardo, G., Nicoletti, F., Rizzarelli, E., & Copani, A. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.2.83 · Cited by 91
Striatal-enriched Protein-tyrosine Phosphatase (STEP) Regulates Pyk2 Kinase Activity
Xu, J., Kurup, P., Bartos, J. A., Patriarchi, T., Hell, J. W., & Lombroso, P. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.368654 · Cited by 91
Self-citationLee, L., Sakurai, M., Matsuzaki, S., Arancio, O., & Fraser, P. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8257-7 · Cited by 91
“Post-synaptically, for example, Ab has been shown to perturb receptor trafficking and spine density/ morphology (Snyder et al. 2005; Hsieh et al. 2006; Shankar et al. 2007; Wei et al. 2010).”
Mizoguchi, H., Takuma, K., Fukuzaki, E., Ibi, D., Someya, E., Akazawa, K.-H., Alkam, T., Tsunekawa, H., Mouri, A., Noda, Y., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154724 · Cited by 95
“To clarify the mechanism underlying A -induced expression of MMP-9, we focused on the role of NMDA receptors, because it has been reported that A activates NMDA receptors (Snyder et al., 2005), and MMP-9 expression is induced via NMDA receptors (Meighan et al.”
Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
Lee, L., Dale, E., Staniszewski, A., Zhang, H., Saeed, F., Sakurai, M., Fà, M., Orozco, I. J., Michelassi, F. E., Akpan, N., et al. (2014) · Scientific Reports · doi:10.1038/srep07190 · Cited by 102
Venkitaramani, D. V., Paul, S., Zhang, Y., Kurup, P., Ding, L., Tressler, L., Allen, M., Sacca, R., Picciotto, M. R., & Lombroso, P. J. (2009) · Synapse · doi:10.1002/syn.20608 · Cited by 90
“The tyrosine kinase Fyn and the NR2B subunit of the N-methyl-D-aspartate receptor (NMDAR) are two additional substrates of STEP that are also involved in the regulation of synaptic plasticity (Braithwaite et al., 2006; Nguyen et al., 2002).”
BackgroundInfluentialSelf-citationA β Internalization by Neurons and Glia
Mohamed, A., & Posse de Chaves, E. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/127984 · Cited by 90
Zempel, H., & Mandelkow, E.-M. (2012) · Neurodegenerative Diseases · doi:10.1159/000332816 · Cited by 90
Kuszczyk, M. A., Sanchez, S., Pankiewicz, J., Kim, J., Duszczyk, M., Guridi, M., Asuni, A. A., Sullivan, P. M., Holtzman, D. M., & Sadowski, M. J. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.034 · Cited by 97
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines(47,48) and reduces expression of NMDARs and related synaptic proteins,(49) through several signaling pathway…”
Wong, H., Levenga, J., Cain, P., Rothermel, B., Klann, E., & Hoeffer, C. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1499-8 · Cited by 89
“%( epols time (min) WT TG 1 2 1 2 1 2 WT TG 1 2 young WT young TG aged WT aged TG 2 mV 2 ms 1 2 WT TG 1 2 2 mV 2 ms 1 2 WT TG 1 2 1 2 1 2 2 mV 2 ms 1 2 1 2 2 ms 2 mV d aged WT aged TG GAPDH p-GluA1 (S845) p-GluA1 (S831) GluA1 p-CaMKII (T286) CaMKIIα p-ERK1 ERK1 p-ERK2 ERK2 WT TG aged im m un or ea ct iv ity (% o f a g…”
InfluentialSmall, D. H., Maksel, D., Kerr, M. L., Ng, J., Hou, X., Chu, C., Mehrani, H., Unabia, S., Azari, M. F., Loiacono, R., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04444.x · Cited by 69
Jürgensen, S., Antonio, L. L., Mussi, G. E. A., Brito-Moreira, J., Bomfim, T. R., De Felice, F. G., Garrido-Sanabria, E. R., Cavalheiro, É. A., & Ferreira, S. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177790 · Cited by 88
Rahimi, F., Shanmugam, A., & Bitan, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533358 · Cited by 88
Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
Marttinen, M., Takalo, M., Natunen, T., Wittrahm, R., Gabbouj, S., Kemppainen, S., Leinonen, V., Tanila, H., Haapasalo, A., & Hiltunen, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00963 · Cited by 88
“Furthermore, several studies have demonstrated that pathological elevation of Aβ levels reduces glutamatergic synaptic transmission, resulting in synapse loss (Snyder et al., 2005; Tackenberg et al., 2013; Tu et al., 2014).”
BackgroundDu, Y., Fu, M., Huang, Z., Tian, X., Li, J., Pang, Y., Song, W., Tian Wang, Y., & Dong, Z. (2020) · Aging Cell · doi:10.1111/acel.13113 · Cited by 95
“…et al., 2005), while in vivo administration of Aβ impairs synaptic plasticity (Shankar et al., 2008) and cognitive function by binding with AMPARs (Hsieh et al., 2006) or N-methyl-D-aspartic acid receptors (NMDARs) (Kamenetz et al., 2003; Snyder et al., 2005) to cause their internalization.”
BackgroundPark, K., Lee, J., Jang, H. J., Richards, B. A., Kohl, M. M., & Kwag, J. (2020) · BMC Biology · doi:10.1186/s12915-019-0732-7 · Cited by 85
Pathogenesis of Abeta Oligomers in Synaptic Failure
Sivanesan, S., Tan, A., & Rajadas, J. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310030011 · Cited by 86
“Of notable interest, a novel mechanism which governs A involved NMDA internalization for synapse damage requires 7 nicotinic AChRs ([109].”
BackgroundBrody, A. H., & Strittmatter, S. M. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.09.007 · Cited by 86
“…of NDMA receptors in cultured cortical neurons through a mechanism involving the binding of Aβ to α7nAChR and the subsequent activation of the striatally enriched phosphatase (STEP) via dephosphorylation by the Ca2 +- sensitive phosphatase PP2B, also known as calcineurin (Snyder et al., 2005).”
InfluentialBeta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons
Kelly, B. L., & Ferreira, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.047 · Cited by 85
Synaptic dysfunction in early phases of Alzheimer's Disease
(2022) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-819410-2.00022-9 · Cited by 83
Locus coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease
Ross, J. A., McGonigle, P., & Van Bockstaele, E. J. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.09.002 · Cited by 84
The Prion Protein Ligand, Stress-Inducible Phosphoprotein 1, Regulates Amyloid-β Oligomer Toxicity
Ostapchenko, V. G., Beraldo, F. H., Mohammad, A. H., Xie, Y.-F., Hirata, P. H. F., Magalhaes, A. C., Lamour, G., Li, H., Maciejewski, A., Belrose, J. C., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3214-13.2013 · Cited by 85
“A 1– 42 has been shown to interact with 7nAChRs (Wang et al., 2000; Magdesian et al., 2005; Snyder et al., 2005), which is thought to play an important role in AD (Hernandez and Dineley, 2012).”
Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices
Sebollela, A., Freitas-Correa, L., Oliveira, F. F., Paula-Lima, A. C., Saraiva, L. M., Martins, S. M., Mota, L. D., Torres, C., Alves-Leon, S., de Souza, J. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298471 · Cited by 85
Roselli, F., Hutzler, P., Wegerich, Y., Livrea, P., & Almeida, O. F. X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006011 · Cited by 84
“physiology: (i) soluble Ab levels correlate strongly with loss of synapses as well as with severity of cognitive impairment in AD patients [6] and in transgenic mouse models [7,45], (ii) Ab oligomers acutely impair synaptic plasticity and cognitive functions [3,7,8], and (iii) Ab oligomers influence the overall levels…”
Novel neuroprotective effects of the aqueous extracts from Verbena officinalis Linn
Lai, S.-W., Yu, M.-S., Yuen, W.-H., & Chang, R. C. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.009 · Cited by 98
Cahill, E., Salery, M., Vanhoutte, P., & Caboche, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00172 · Cited by 111
“In striatal neurons, D1R stimulation leads to an increase in Ca2+ influx through NMDARs via SFK/Fyn-induced phosphorylation of the GluN2B subunit at Tyr1472.”
InfluentialHoe, H., Lee, H., & Pak, D. T. S. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00221.x · Cited by 83
Hu, N.-W., Smith, I. M., Walsh, D. M., & Rowan, M. J. (2008) · Brain · doi:10.1093/brain/awn174 · Cited by 84
“Since application of Ab 42 can rapidly reduce NMDA receptor surface expression and NMDA evoked currents in certain cortical neurons (Snyder et al., 2005), Ab might be expected to reduce NMDA receptor-dependent hyperaemia.”
Oh, S. H., Kim, H. N., Park, H. J., Shin, J. Y., Bae, E.-J., Sunwoo, M. K., Lee, S.-J., & Lee, P. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.075 · Cited by 84
“Amyloid-b could decrease the surface expression of NMDA receptors by promoting endocytosis of receptor proteins (Sakono and Zako, 2010; Snyder et al., 2005), which is quite in accordance with the present result.”
ECM in brain aging and dementia
Morawski, M., Filippov, M., Tzinia, A., Tsilibary, E., & Vargova, L. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00010-4 · Cited by 84
“, 2005), and Ab also promoted the endocytosis of NMDA receptors in the cortical neurons (Snyder et al., 2005).”
Chévere-Torres, I., Kaphzan, H., Bhattacharya, A., Kang, A., Maki, J. M., Gambello, M. J., Arbiser, J. L., Santini, E., & Klann, E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.028 · Cited by 83
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 83
Ni, R., Marutle, A., & Nordberg, A. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121447 · Cited by 82
Tang, B. L. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7254 · Cited by 83
Zhang, X., He, X., Chen, Q., Lu, J., Rapposelli, S., & Pi, R. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.12.042 · Cited by 87
Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 82
“These modifications could result from boosted NMDAR endocytosis and decreased NMDAR expression brought on by Aβ [98].”
BackgroundShemer, I., Holmgren, C., Min, R., Fülöp, L., Zilberter, M., Sousa, K. M., Farkas, T., Härtig, W., Penke, B., Burnashev, N., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04733.x · Cited by 82
“In support of this hypothesis, Snyder et al. (2005)”
Gladding, C. M., Sepers, M. D., Xu, J., Zhang, L. Y. J., Milnerwood, A. J., Lombroso, P. J., & Raymond, L. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds154 · Cited by 82
“It has been shown in several studies that the fusion proteins efficiently enter cells due to the presence of the HIV-1 TAT protein transduction domain (31,38,39).”
Self-citationThe Emergence of NMDA Receptor Metabotropic Function: Insights from Imaging
Dore, K., Aow, J., & Malinow, R. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00020 · Cited by 82
“…synaptic transmission and induces synapse loss in various hippocampal preparations (Chapman et al., 1999; Larson et al., 1999; Walsh et al., 2002; Wang et al., 2002; Kamenetz et al., 2003; Snyder et al., 2005; Hsieh et al., 2006; Shankar et al., 2007; Wei et al., 2010; Birnbaum et al., 2015).”
BackgroundInfluentialUnderstanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease
Stockley, J. H., & O’Neill, C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8271-3 · Cited by 103
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 91
“Although there might be a single receptor that mediates Ab toxicity at the postsynaptic compartment, it seems more likely that several postsynaptic receptors are involved, such as prion proteins, a7-nicotinergic receptors, metabotropic glutamate receptors, and in particular, NMDA receptors (Lauren et al., 2009; Shanka…”
InfluentialProspects for Improving Brain Function in Individuals with Down Syndrome
Costa, A. C. S., & Scott-McKean, J. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0089-3 · Cited by 89
“promotes the endocytosis of NMDA receptors [170] and is associated with AD.”
New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
Corona, C., Pensalfini, A., Frazzini, V, & Sensi, S. L. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.57 · Cited by 80
Carty, N., Xu, J., Kurup, P., Brouillette, J., Goody, S. M. G., Austin, D. R., Yuan, P., Chen, G., Correa, P. R., Haroutunian, V., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.63 · Cited by 85
“Taken together, our findings indicate that MK-801 increased STEP61 levels and activity, decreased the tyrosine phosphorylation of STEP61 substrates and reduced the surface expression of GluN2B-containing NMDARs.”
InfluentialSelf-citationJNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
Musi, C. A., Agrò, G., Santarella, F., Iervasi, E., & Borsello, T. (2020) · Cells · doi:10.3390/cells9102190 · Cited by 73
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
“APP23Tg and Tg2576 mice have been helpful for identifying changes in N-methyl-D-aspartate (NMDA) receptor traffic or altered response to the MK-801 antag- onist (Snyder et al. 2005; Balducci et al. 2010b).”
Di, X., Yan, J., Zhao, Y., Zhang, J., Shi, Z., Chang, Y. Z., & Zhao, B. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.019 · Cited by 81
Aleksis, R., Oleskovs, F., Jaudzems, K., Pahnke, J., & Biverstål, H. (2017) · Biochimie · doi:10.1016/j.biochi.2017.07.011 · Cited by 89
Amyloid, APP, and Electrical Activity of the Brain
Hefter, D., Ludewig, S., Draguhn, A., & Korte, M. (2020) · The Neuroscientist · doi:10.1177/1073858419882619 · Cited by 78
“Synthetic A β 42 peptides as well as naturally secreted A β from APP/PS1 transgenic mice promote the endocytosis of NMDAR from the postsynaptic surface, depressing the NMDAR current in wild-type cortical neurons (Snyder and others 2005).”
BackgroundMechanisms of action of amyloid-beta and its precursor protein in neuronal cell death
Leong, Y. Q., Ng, K. Y., Chye, S. M., Ling, A. P. K., & Koh, R. Y. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00516-y · Cited by 88
Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies
Shrestha, P., Katila, N., Lee, S., Seo, J. H., Jeong, J., & Yook, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113591 · Cited by 101
Jarvis, C. I., Goncalves, M. B., Clarke, E., Dogruel, M., Kalindjian, S. B., Thomas, S. A., Maden, M., & Corcoran, J. P. T. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07426.x · Cited by 78
“By using the glucocorticoid dexamethasone, we have shown here that the production of Ab is increased in embryonic mouse cortical neurons, and similar data have been obtained in N2A and PC12 cells (Snyder et al., 2005; Green et al., 2006), further”
Criscuolo, C., Fontebasso, V., Middei, S., Stazi, M., Ammassari-Teule, M., Yan, S. S., & Origlia, N. (2017) · Scientific Reports · doi:10.1038/srep42370 · Cited by 77
“In particular, synthetic oligomeric A β (1–42) in the nanomolar range was shown to specifically inhibit LTP in the hippocampus 44–49 and cortical areas, including the EC 23,37,50 ; whereas higher micromolar concentrations caused synaptic depression and LTD impairment 24,51–53 .”
The Ubiquitin System in Alzheimer’s Disease
Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 85
Gong, Y., & Lippa, C. F. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317510382893 · Cited by 76
“In the AD brain, oligomers of Abmay block the activity of a7nAChR effecting on the endocytosis of NMDA receptors.(47)”
Epilepsy and Alzheimer’s Disease: Potential mechanisms for an association
Giorgi, F. S., Saccaro, L. F., Busceti, C. L., Biagioni, F., & Fornai, F. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.009 · Cited by 76
Rahim, M. A., Nakajima, A., Saigusa, D., Tetsu, N., Maruyama, Y., Shibuya, M., Yamakoshi, H., Tomioka, Y., Iwabuchi, Y., Ohizumi, Y., et al. (2009) · Biochemistry · doi:10.1021/bi901088w · Cited by 77
Chang, Y. C., Kim, H., Rapoport, S. I., & Rao, J. S. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9731-8 · Cited by 80
“ing Alzheimer disease [9, 10], Parkinson disease [11], Huntington disease [12], schizophrenia [13], and bipolar”
Overactivation of calcineurin induced by amyloid-beta and prion proteins
Agostinho, P. M., Lopes, J. P., Velez, Z., & Oliveira, C. R. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.01.005 · Cited by 76
“Moreover, it was demonstrated that Ab peptides can induce CaN activation, via Ca2+ influx through a7 nicotinic acetylcholine receptors, in cortical neurons (Snyder et al., 2005).”
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer’s disease
Epis, R., Marcello, E. E., Gardoni, F., Vastagh, C., Malinverno, M., Balducci, C., Colombo, A. V., Borroni, B., Vara, H., Dell’Agli, M., et al. (2010) · Brain · doi:10.1093/brain/awq217 · Cited by 93
“Recently, an effect of Ab oligomers on NMDA receptor subunits has been reported, revealing an effect on NR2B trafficking and internalization (Snyder et al., 2005; Lacor et al., 2007).”
AMPA Receptor Trafficking in Natural and Pathological Aging
Jurado, S. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00446 · Cited by 76
“Alternatively, soluble Aβ may affect LTP induction by reducing surface expression of NMDARs (Snyder et al., 2005).”
Background
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.